Tell888.743.7576 x84

2013 Life Sciences (Pharmaceuticals) Industry Perspective

In a post from December 2012, booz&co. discusses the exciting opportunities in life sciences in 2013:

The year 2012 has passed into history, and what a year it was for biopharmaceuticals. In the United States, the Supreme Court affirmed the new healthcare reform law and exempted pharma companies from sales force overtime rules, the Food & Drug Administration (FDA) approved the first obesity drug in 13 years with Belviq, and billions of dollars changed hands as a result of government settlements…. (read the full article here)




Leave a Reply